The establishment and/or the maintenance of a data governance plan was inadequate. The traceability, legibility, documentation, formatting, and/or the accuracy of records was inadequate. The creation, maintenance, processing, and/or review of laboratory data was inadequate.
Inspection Record
JP Laboratories — Health Canada Inspection Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
The training of personnel before new or revised standard operating procedures were implemented was inadequate.
The calibration, inspection, and/or qualification of the equipment, including computerized systems, was inadequate.
Test methods were not validated or the method transfer studies were not conducted.
The handling and/or storage of samples was inadequate for raw materials, drugs being processed, bulk drugs, and/or finished products.
The availability, content and/or maintenance of the quality agreements between the supplier, fabricator, tester, packager, labeller, distributor, importer, and/or wholesaler was inadequate.
The electronic system was not validated for its intended use.
The recorded information or details were inadequate.
About this record
Extracted automatically from the document of the Health Canada inspection on 2026-01-06. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
